Skip to main content
. 2020 Jul 13;12(7):1880. doi: 10.3390/cancers12071880

Figure 4.

Figure 4

C2C12 Myotube metabolic profile identified in C2C12 cells. Concentration of (a) Aspartate; (b) Choline; (c) Dimethylamine; (d) Glucose-6-phosphate; (e) Glutamine; (f) N-Acetyllysine; (g) Sarcosine. C2C12 myotube cells were distributed into control (C); leucine supplementation medium (L); Walker Factor treatment (WF) and Walker Factor treatment and leucine supplementation medium (WFL). Data were expressed as mean ± standard deviation (SD) and analysed by one-way ANOVA followed by Tukey. (a) p < 0.05 comparison to C; (b) p < 0.05 comparison to L and (c) p < 0.05 comparison to W.